Quest Diagnostics offers the Interstitial Lung Disease (ILD) Panel for simultaneous testing of biomarkers associated with CTD-ILD using one test code for ease of ordering (Table).

Interstitial Lung Disease Panel - A subset of interstitial lung disease (ILD) patients have underlying connective tissue diseases (CTDs). This panel serves as an aid for the diagnosis of CTDs, including rheumatoid arthritis, inflammatory myositis, systemic sclerosis, and Sjogren’s syndrome, that are associated with the development of ILD.

Interstitial Lung Disease (ILD) can complicate several collagen vascular diseases including Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Sjogren's Syndrome, Systemic Lupus Erythematosis, Rheumatoid Arthritis, and ANCA-Associated Vasculitis.

Jan 21, 2025 · May be useful for evaluation of interstitial lung disease in the context of systemic autoimmune rheumatic disease (ie, connective tissue disease). ||Separate from cells ASAP or within 2 hours of collection.

This antibody panel test may be useful for the evaluation of patients with ILD. Panel tests that detect a variety of autoantibodies are the most effective approach to identify connective tissue disease-associated ILD.

Feb 27, 2023 · The diffuse parenchymal lung diseases (DPLD), often collectively referred to as the interstitial lung diseases (ILDs), are a heterogeneous group of disorders that are classified together because of similar clinical, radiographic, physiologic, or pathologic manifestations (algorithm 1) [1-5].

Idiopathic pulmonary fibrosis (IPF), the most common interstitial lung disease (ILD), has been associated with pathogenic variants in genes encoding telomerases (TERT, TERC). These pathogenic variants lead to telomerase dysfunction, impaired maintenance of telomeres, and reduced telomere length.

Identifying an underlying autoimmune disorder in ILD patients has critical importance in therapuetic decision-making and has a meaningful impact on prognosis. This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.

ILD Antibody Panel detects autoantibodies linked to interstitial lung disease and systemic rheumatic diseases with Mitogen's ILD Antibody Profile.

In some patients, interstitial lung disease (ILD) may be the first manifestation of a connective tissue disease. Workup of the ILD should include a thorough autoimmune evaluation (ie, serologic testing) to identify an associated connective tissue disease. Panel tests that detect a variety of autoantibodies are the most efficient testing approach.